Esther Masiá

400 citations
16 papers · 322 indexed · h-index 9
Topics
RNA Interference and Gene Delivery (5 papers)Nanoparticle-Based Drug Delivery (4 papers)Nanoplatforms for cancer theranostics (3 papers)
Partner nations
SpainGermanyItaly

In The Last Decade

Esther Masiá

15 papers receiving 320 citations

Peers

Esther Masiá
Comparison fields: 5 of 61
  • Molecular Biology 190
  • Cancer Research 158
  • Biomaterials 53
  • Biomedical Engineering 38
  • Pulmonary and Respiratory Medicine 36
Replace Dattatrya Shetti with:
Dattatrya Shetti China
Cristina Manguán-García Spain
Vahideh Zarrin Iran
Kyle B. Matchett United Kingdom
Paweena Dana Thailand
Luana Adamo Italy
Huaixin Xing China
Violette M. Renard United States
Naitik Jain India
Weihan Yang China
Esther Masiá relative to Dattatrya Shetti China Dattatrya Shetti's profile →
Citations per field
00.5×2.8×
Dattatrya Shetti · 1×
Citations per year

Countries citing papers authored by Esther Masiá

Since Specialization
Citations

This map shows the geographic impact of Esther Masiá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Masiá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Masiá more than expected).

Fields of papers citing papers by Esther Masiá

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Masiá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Masiá. The network helps show where Esther Masiá may publish in the future.

Co-authorship network of co-authors of Esther Masiá

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Masiá. A scholar is included among the top collaborators of Esther Masiá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Masiá. Esther Masiá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 6
3 7
4 4
5 5
6 1
7 8
8 8
9 5
10 8
11 43
12 39
13 54
14 8
15 107
16 19

About Esther Masiá

Esther Masiá is a scholar working on Biomaterials, Cancer Research and Neurology, having authored 16 papers that have together received 322 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Cancer Research (158 citations), Pharmaceutical Science (29 citations) and Biomaterials (53 citations). Esther Masiá has collaborated with scholars based in Spain, Germany and Italy. Frequent co-authors include Marı́a J. Vicent, Ana Armiñán, Ana Calatrava, Katia Scotlandi, J. Rubio‐Briones, Caterina Mancarella, Irene Casanova‐Salas, José Antonio López‐Guerrero, Vicent J. Nebot and Luis Rubio. Their work appears in journals such as Advanced Materials, PLoS ONE and Chemistry of Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026